Opin vísindi

A proteogenomic signature of age-related macular degeneration in blood

Skoða venjulega færslu

dc.contributor.author Emilsson, Valur
dc.contributor.author Gudmundsson, Elias F
dc.contributor.author Jonmundsson, Thorarinn
dc.contributor.author Jonsson, Brynjolfur G
dc.contributor.author Twarog, Michael
dc.contributor.author Gudmundsdottir, Valborg
dc.contributor.author Li, Zhiguang
dc.contributor.author Finkel, Nancy
dc.contributor.author Poor, Stephen
dc.contributor.author Liu, Xin
dc.contributor.author Esterberg, Robert
dc.contributor.author Zhang, Yiyun
dc.contributor.author Jose, Sandra
dc.contributor.author Huang, Chia-Ling
dc.contributor.author Liao, Sha-Mei
dc.contributor.author Loureiro, Joseph
dc.contributor.author Zhang, Qin
dc.contributor.author Grosskreutz, Cynthia L
dc.contributor.author Nguyen, Andrew A
dc.contributor.author Huang, Qian
dc.contributor.author Leehy, Barrett
dc.contributor.author Pitts, Rebecca
dc.contributor.author Aspelund, Thor
dc.contributor.author Lamb, John R
dc.contributor.author Jonasson, Fridbert
dc.contributor.author Launer, Lenore J
dc.contributor.author Cotch, Mary Frances
dc.contributor.author Jennings, Lori L
dc.contributor.author Gudnason, Vilmundur
dc.contributor.author Walshe, Tony E
dc.date.accessioned 2022-08-23T01:03:29Z
dc.date.available 2022-08-23T01:03:29Z
dc.date.issued 2022-06-13
dc.identifier.citation Emilsson , V , Gudmundsson , E F , Jonmundsson , T , Jonsson , B G , Twarog , M , Gudmundsdottir , V , Li , Z , Finkel , N , Poor , S , Liu , X , Esterberg , R , Zhang , Y , Jose , S , Huang , C-L , Liao , S-M , Loureiro , J , Zhang , Q , Grosskreutz , C L , Nguyen , A A , Huang , Q , Leehy , B , Pitts , R , Aspelund , T , Lamb , J R , Jonasson , F , Launer , L J , Cotch , M F , Jennings , L L , Gudnason , V & Walshe , T E 2022 , ' A proteogenomic signature of age-related macular degeneration in blood ' , Nature Communications , vol. 13 , no. 1 , 3401 . https://doi.org/10.1038/s41467-022-31085-x
dc.identifier.issn 2041-1723
dc.identifier.other 51747860
dc.identifier.other bb82667f-5169-4789-a661-570e964b26ae
dc.identifier.other 35697682
dc.identifier.other 85132050170
dc.identifier.other unpaywall: 10.1038/s41467-022-31085-x
dc.identifier.uri https://hdl.handle.net/20.500.11815/3332
dc.description © 2022. The Author(s). Funding Information: The authors acknowledge the contribution of the Icelandic Heart Association (IHA) staff to the AGES-RS, as well as the involvement of all study participants. We thank the IAMDGC consortium for supplying us with their GWAS summary statistics data. National Institute on Aging (NIA) contracts N01-AG-12100 and HHSN271201200022C for V.G. financed the AGES study; retinal image collection and AMD readings were funded by the NIH Intramural Research Program (ZIAEY000401). V.G. received a funding from the NIA (1R01AG065596), and IHA received a support from Althingi (the Icelandic Parliament). The Icelandic Research Fund (IRF) funded V.E. and Va.G. with grants 195761-051, 184845-053, and 206692-051, while Va.G. received a postdoctoral research grant from the University of Iceland Research Fund Funding Information: The study was supported by the Novartis Institute for Biomedical Research. M.T., N.F., S.P., X.L., R.E., Y.Z., S.J., C.L.H., S.M.L., J.L., C.L.G., A.A.N., B.L., R.P., Z.L., L.L.J., T.E.W., Q.Z., Q.H., and J.R.L. are employees and stockholders of Novartis. All other authors have no conflict of interests to declare. Publisher Copyright: © 2022, The Author(s).
dc.description.abstract Age-related macular degeneration (AMD) is one of the most common causes of visual impairment in the elderly, with a complex and still poorly understood etiology. Whole-genome association studies have discovered 34 genomic regions associated with AMD. However, the genes and cognate proteins that mediate the risk, are largely unknown. In the current study, we integrate levels of 4782 human serum proteins with all genetic risk loci for AMD in a large population-based study of the elderly, revealing many proteins and pathways linked to the disease. Serum proteins are also found to reflect AMD severity independent of genetics and predict progression from early to advanced AMD after five years in this population. A two-sample Mendelian randomization study identifies several proteins that are causally related to the disease and are directionally consistent with the observational estimates. In this work, we present a robust and unique framework for elucidating the pathobiology of AMD.
dc.format.extent 1690881
dc.format.extent
dc.language.iso en
dc.relation.ispartofseries Nature Communications; 13(1)
dc.rights info:eu-repo/semantics/openAccess
dc.subject Augnlæknisfræði
dc.subject Aged
dc.subject Genetic Loci
dc.subject Genome-Wide Association Study
dc.subject Humans
dc.subject Macular Degeneration/genetics
dc.subject Mendelian Randomization Analysis
dc.subject Proteogenomics
dc.subject Risk Factors
dc.subject Augnbotnar
dc.subject Multidisciplinary
dc.subject General Physics and Astronomy
dc.subject General Chemistry
dc.subject General Biochemistry,Genetics and Molecular Biology
dc.title A proteogenomic signature of age-related macular degeneration in blood
dc.type /dk/atira/pure/researchoutput/researchoutputtypes/contributiontojournal/article
dc.description.version Peer reviewed
dc.identifier.doi 10.1038/s41467-022-31085-x
dc.relation.url http://www.scopus.com/inward/record.url?scp=85132050170&partnerID=8YFLogxK
dc.contributor.department Faculty of Medicine
dc.contributor.school Health Sciences


Skrár

Þetta verk birtist í eftirfarandi safni/söfnum:

Skoða venjulega færslu